Overall, she said, the campaign is part of Abbott’s work to “chip away” at the obstacles facing people with diabetes as they seek out proper care and treatment. It builds on the stigma ...

In a report released today, Lee Hambright from Bernstein downgraded Tandem Diabetes Care (TNDM – Research Report) to a Hold, with a price ...

Above the Bias, Abbott’s minute-long spot, seeks to address the shame, guilt and misconceptions that often surround diabetes. The short film also delves into how this bias can deter patients from ...

See the world from the perspective of someone living with diabetes and ... posting on behalf of Abbott’s decade-old Libre line of continuous glucose monitors. A Libre logo is shown, along ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) yesterday and set a price ...

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Abbott Diabetes Care was created in 2004 with the acquisition of TheraSense Inc., a leading blood glucose monitoring business. The diagnostics portfolio was expanded with the addition of i-STAT ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery ...

AI isn't just a tool; it's a partner in care. For example, AI can detect early signs of eye damage from diabetes in retinal images as accurately as specialists, which is critical for preventing ...

The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust ...